Clinical Advisor

AACE Updates Guidance on Obesity, Adiposity-Based Chronic Disease

The AACE consensus statement emphasizes improvement of overall health in addition to weight reduction among adults with obesity and adiposity-based chronic disease.
The Manila Times

Novo Nordisk A/S: CagriSema demonstrated 23% weight loss in an open-label head-to-head REDEFINE 4 trial in people with obesity, the primary endpoint was not achie…

CagriSema achieved 23% weight loss after 84 weeks of treatmentCagriSema 2.4/2.4 mg did not meet the primary endpoint of ...

Personal trainer reveals No. 1 red flag in a weight-loss program — that she fell for herself

Weight-loss programs abound on the internet, from customized plans sold by influencers lacking credentials to subscription ...
AOL

Mounjaro for weight loss: What you need to know before starting

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Trying to lose weight can be confusing, with so many different tips and diets out there. And that’s even before you throw in weight ...
Forbes

Ro Body: Weight Loss Medication Review

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...